Theravance Biopharma, Inc. (TBPH)

NASDAQ: TBPH · IEX Real-Time Price · USD

9.57

-0.11 (-1.14%)

At close: Jul 19, 2024, 4:00 PM

9.56

-0.01 (-0.10%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Theravance Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2014
Market Capitalization	465	560	756	814	1,137	1,470	Upgrade
Market Cap Growth	-36.66%	-25.95%	-7.19%	-28.37%	-22.63%	3.64%	Upgrade
Enterprise Value	413	506	480	1,310	1,519	1,698	Upgrade
PE Ratio	-	-10.14	0.87	-4.08	-4.09	-6.21	Upgrade
PS Ratio	7.57	9.75	14.72	14.72	15.82	20.02	Upgrade
PB Ratio	2.27	2.63	1.71	-2.40	-3.74	-6.56	Upgrade
P/FCF Ratio	-25.21	-20.01	-4.07	-3.85	-4.42	-6.09	Upgrade
P/OCF Ratio	-25.72	-20.73	-4.04	-3.92	-4.54	-6.17	Upgrade
EV/Sales Ratio	6.71	8.81	9.34	23.68	21.15	23.14	Upgrade
EV/EBITDA Ratio	-13.20	-12.40	0.45	-7.18	-5.63	-8.49	Upgrade
EV/EBIT Ratio	-10.91	-10.78	0.45	-6.86	-5.47	-8.09	Upgrade
EV/FCF Ratio	-22.12	-18.08	-2.58	-6.20	-5.91	-7.04	Upgrade
Debt / Equity Ratio	0.23	0.23	0.12	-1.98	-2.23	-2.28	Upgrade
Debt / EBITDA Ratio	-1.67	-1.21	0.05	-3.67	-2.51	-2.55	Upgrade
Debt / FCF Ratio	-2.80	-1.76	-0.28	-3.17	-2.63	-2.12	Upgrade
Quick Ratio	5.33	4.87	12.02	3.22	2.94	2.97	Upgrade
Current Ratio	5.74	5.39	12.31	4.26	3.18	3.03	Upgrade
Asset Turnover	0.15	0.13	0.10	0.14	0.13	0.16	Upgrade
Interest Coverage	-14.31	-19.97	166.04	-22.35	-32.52	-6.59	Upgrade
Return on Equity (ROE)	-19.00%	-19.90%	1577.70%	59.70%	120.20%	143.90%	Upgrade
Return on Assets (ROA)	-11.10%	-12.40%	167.20%	-50.40%	-51.70%	-50.40%	Upgrade
Return on Capital (ROIC)	-16.75%	-21.37%	-15.45%	-77.89%	-79.90%	-87.87%	Upgrade
Earnings Yield	-9.62%	-9.86%	115.38%	-24.49%	-24.45%	-16.09%	Upgrade
FCF Yield	-3.68%	-5.00%	-24.57%	-25.94%	-22.60%	-16.42%	Upgrade
Buyback Yield / Dilution	23.28%	24.85%	-5.95%	-11.41%	-12.11%	-3.04%	Upgrade
Total Shareholder Return	23.28%	24.85%	-5.95%	-11.41%	-12.11%	-3.04%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).